Attached files

file filename
EX-5.1 - EX-5.1 - MEDCO HEALTH SOLUTIONS INCy86549exv5w1.htm
EX-4.1 - EX-4.1 - MEDCO HEALTH SOLUTIONS INCy86549exv4w1.htm
EX-4.2 - EX-4.2 - MEDCO HEALTH SOLUTIONS INCy86549exv4w2.htm
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 10, 2010
MEDCO HEALTH SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
     
1-31312   22-3461740
(Commission File Number)   (I.R.S. Employer Identification No.)
     
100 Parsons Pond Drive, Franklin Lakes, NJ   07417
(Address of principal executive offices)   (Zip Code)
Registrant’s telephone number, including area code: 201-269-3400
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 9.01 Financial Statements and Exhibits.
     Medco Health Solutions, Inc. hereby files the following exhibits to, and incorporates such exhibits by reference in, the Registration Statement which was filed on March 12, 2008 and supplemented by the Prospectus Supplement dated on September 7, 2010, or otherwise pursuant to requirements of Form 8-K:
     
4.1
  Form of 2.750% Notes due 2015
     
4.2
  Form of 4.125% Notes due 2020
     
5.1
  Opinion of Sullivan & Cromwell LLP
     
23.1
  Consent of Sullivan & Cromwell LLP (included in Exhibit 5.1)

 


 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  MEDCO HEALTH SOLUTIONS, INC.
 
 
Date: September 10, 2010  By:   /s/ Thomas M. Moriarty    
    Thomas M. Moriarty   
    General Counsel, Secretary and
Senior Vice President 
 

 


 

         
EXHIBIT INDEX
     
Exhibit No.   Description
4.1
  Form of 2.750% Notes due 2015
     
4.2
  Form of 4.125% Notes due 2020
     
5.1
  Opinion of Sullivan & Cromwell LLP
     
23.1
  Consent of Sullivan & Cromwell LLP (included in Exhibit 5.1)